You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

AUROBINDO PHARMA Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for AUROBINDO PHARMA, and what generic and branded alternatives to AUROBINDO PHARMA drugs are available?

AUROBINDO PHARMA has four hundred and eighty-four approved drugs.

There are nineteen tentative approvals on AUROBINDO PHARMA drugs.

Drugs and US Patents for AUROBINDO PHARMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SOLUTION;ORAL 090750-001 Feb 2, 2010 OTC No No ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd HALOPERIDOL haloperidol TABLET;ORAL 218789-001 Apr 19, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Usa RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201971-002 May 15, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 206069-002 Mar 6, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE metformin hydrochloride; pioglitazone hydrochloride TABLET;ORAL 200823-001 Feb 13, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 078619-003 Jan 31, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078327-002 Aug 10, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AUROBINDO PHARMA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aurobindo Pharma Usa MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,105,783 ⤷  Sign Up
Aurobindo Pharma Usa MAXZIDE-25 hydrochlorothiazide; triamterene TABLET;ORAL 019129-003 May 13, 1988 4,444,769 ⤷  Sign Up
Aurobindo Pharma Usa MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,444,769 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.